C12R 2001/44
Staphylococcus
C12R2001/44 (Staphylococcus) appears on 80 US grants and 141 published applications in this corpus.
Search patents in C12R- Granted patents
- 80
- Published applications
- 141
- Assignees
- 111
- Inventors
- 365
- Latest grant
- 11 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1979 | 1 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 2 | 0 |
| 1983 | 0 | 0 |
| 1984 | 1 | 0 |
| 1985 | 0 | 0 |
| 1986 | 2 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 1 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 1 | 0 |
| 1998 | 0 | 0 |
| 1999 | 1 | 0 |
| 2000 | 3 | 0 |
| 2001 | 1 | 0 |
| 2002 | 0 | 2 |
| 2003 | 1 | 1 |
| 2004 | 0 | 0 |
| 2005 | 1 | 3 |
| 2006 | 0 | 1 |
| 2007 | 0 | 3 |
| 2008 | 2 | 2 |
| 2009 | 2 | 2 |
| 2010 | 1 | 5 |
| 2011 | 5 | 2 |
| 2012 | 1 | 2 |
| 2013 | 3 | 2 |
| 2014 | 1 | 1 |
| 2015 | 4 | 5 |
| 2016 | 3 | 9 |
| 2017 | 6 | 3 |
| 2018 | 3 | 3 |
| 2019 | 2 | 4 |
| 2020 | 4 | 5 |
| 2021 | 3 | 7 |
| 2022 | 4 | 22 |
| 2023 | 6 | 13 |
| 2024 | 5 | 20 |
| 2025 | 6 | 14 |
| 2026 | 4 | 10 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Antimicrobial therapy11 Aug 2026US 12,702,686 B2The Regents of the University of California
- Pharmaceutical composition for prevention, amelioration, or treatment of skin disease24 Mar 2026US 12,582,680 B2Keio University
- Oral vaccine via dental bacteria and emitted peptides to prevent COVID-19 infection3 Feb 2026US 12,539,328 B2
- Immunoglobulin-binding protein and affinity support using same6 Jan 2026US 12,516,134 B2Jsr Corporation
- Auxotrophic strains of Staphylococcus bacterium23 Dec 2025US 12,503,691 B2Azitra Inc
- Composition for treating ringworm30 Jul 2026US 2026/0216258 A1Maruho Co., Ltd.
- Compositions and methods relating to epigenetic modulation30 Jul 2026US 2026/0218148 A1Duke University
- Composition for caring for keratin materials, comprising at least indole-3-lactic acid, indole-3-carboxaldehyde, indole-3-acetic acid and an adjuvant, uses and process implementing the composition23 Jul 2026US 2026/0207457 A1L'oreal
- Affibody binding specifically to cd137 and use thereof23 Jul 2026US 2026/0209371 A1Abclon Inc.
- Bacterial lysins and uses thereof2 Jul 2026US 2026/0183372 A1Huazhong Agricultural University
Most cited
By later US patents
- Bacterium-contained hydrogel and method of making the same20US 10,617,769 B2Tci Co., Ltd. · 2020
- Compositions and methods for treatment of microbial infections20US 6,929,798 B2Immunology Laboratories, Inc. · 2005
- Auxiliary genes and proteins of methicillin resistant bacteria and antagonists thereof16US 6,251,647 B1The Rockefeller University · 2001
- Compositions and methods for treatment of microbial infections16US 7,329,409 B2Immunology Laboratories, Inc. · 2008
- Auxiliary genes and proteins of methicillin resistant bacteria and antagonists thereof15US 6,013,507 AThe Rockefeller University · 2000